Tumor Mutation Signatures (MSI/MMRd, HRD, POLE/POLD1, CDK12) in Cancer: What Is Their Correlation With Heritable Risk Factors & Targeted Therapy? Can They Help in Germline Cancer Workup?

16 views
February 15, 2021
0 Comments
Login to view comments. Click here to Login
UChicago Genetics in Clinical Cancer Care